ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 598,98
0,03%
DAX
18 068,21
0,26%
Brent Oil
83,015
1,08%
Bitcoin
65 420,00
-1,83%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nexvet Biopharma Plc - Ordinary Shares (NVET)

  7. Nexvet Biopharma Plc - Ordinary Shares (NVET) Actualités

NVET

NEXVET BIOPHARMA PLC (NVET)

Nexvet Biopharma Plc - Ordinary Shares
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVET
DateHeureSourceTitreSymboleSociété
13/02/201822h42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/08/201722h07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
08/08/201723h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/08/201722h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201715h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201715h02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201714h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201714h45Edgar (US Regulatory)(25-NSE)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201714h00Business WireZoetis Completes Acquisition of Nexvet BiopharmaNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
28/07/201714h51GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(d) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/07/201715h56GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(c) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
05/07/201716h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
05/07/201711h30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 2.10 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
03/07/201711h30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Supplement AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
19/06/201722h07PR Newswire (US)WeissLaw LLP Files Class Action Lawsuit Against Nexvet Biopharma PLCNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
16/06/201711h30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 15 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
13/06/201719h07Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
07/06/201706h11GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(b) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/06/201723h20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/06/201714h30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
01/06/201722h14PR Newswire (US)Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Nexvet Biopharma Public Limited Company - NVETNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201723h14Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201712h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201711h30GlobeNewswire Inc.Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
14/04/201703h02Business WireZoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion AnimalsNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
22/02/201711h30GlobeNewswire Inc.Nexvet to Present at the Cowen and Company 37th Annual Health Care ConferenceNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/02/201711h30GlobeNewswire Inc.Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/01/201723h57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/01/201723h00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
12/12/201611h30GlobeNewswire Inc.Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in CatsNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:NVET

Dernières Valeurs Consultées

EU
DG
Vinci
EU
BN
Danone
EU
ACA
Credit Agricole
NYSE
MRK
Merck
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
EU
SGO
Cie de SaintGobain
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés